We envision a world where no one dies of tuberculosis. However, this cannot be achieved without improved, faster-acting, and affordable tuberculosis drug regimens that are available to all who need them. These new cures can bring renewed health, hope, and prosperity to millions. 

Since our inception in 2000, TB Alliance has led the global search for and development of new TB regimens, catalyzing the field and convening cross-sector partnerships to forge the progress that is urgently needed for better TB treatments.

Health Care

Tobacco

TB Alliance

Mel Spigelman

Nader Fotouhi

Maria Beumont

Majda Benhayoun

Kathleen Schostack

Sandeep Juneja

Colleen Pero

Angela Vanderploeg

Pietro Turilli

The Leadership Team at TB Alliance is responsible for steering the organization's mission to develop and deliver improved, faster-acting, and affordable tuberculosis drug regimens. This team ensures strategic alignment, oversees critical operations, manages partnerships, and drives the scientific and financial initiatives necessary to advance TB treatment advancements globally.

Leadership Team

Scientific and Research Team

Clinical Operations Team

Leadership Team

About

Team members

Other teams at TB Alliance

Scientific and Research Team

Clinical Operations Team